The Metastatic Infiltration at the Metastasis/brain Parenchyma-interface is Very Heterogeneous and Has a Significant Impact on Survival in a Prospective Study
Overview
Authors
Affiliations
Unlabelled: The current approach to brain metastases resection is macroscopic removal of metastasis until reaching the glial pseudo-capsule (gross total resection (GTR)). However, autopsy studies demonstrated infiltrating metastatic cells into the parenchyma at the metastasis/brain parenchyma (M/BP)-interface.
Aims/methods: To analyze the astrocyte reaction and metastatic infiltration pattern at the M/BP-interface with an organotypic brain slice coculture system. Secondly, to evaluate the significance of infiltrating metastatic tumor cells in a prospective biopsy study. Therefore, after GTR, biopsies were obtained from the brain parenchyma beyond the glial pseudo-capsule and analyzed histomorphologically.
Results: The coculture revealed three types of cancer cell infiltration. Interestingly, the astrocyte reaction was significantly different in the coculture with a benign, neuroectodermal-derived cell line. In the prospective biopsy study 58/167 (34.7%) samples revealed infiltrating metastatic cells. Altogether, 25/39 patients (64.1%) had proven to exhibit infiltration in at least one biopsy specimen with significant impact on survival (OS) (3.4 HR; p = 0.009; 2-year OS was 6.6% versus 43.5%). Exceptionally, in the non-infiltrating cohort three patients were long-term survivors.
Conclusions: Metastatic infiltration has a significant impact on prognosis. Secondly, the astrocyte reaction at the M/BP-interface is heterogeneous and supports our previous concept of the organ-specific defense against metastatic (organ-foreign) cells.
Fluorescence-Guided Surgery Using 5-Aminolevulinic Acid/Protoporphyrin IX in Brain Metastases.
Price A, Bernstock J, Truong N, Wu K, Lee J, Tucker I Neurosurg Pract. 2025; 5(4):e00121.
PMID: 39959547 PMC: 11809973. DOI: 10.1227/neuprac.0000000000000121.
Pisano F, Masmudi-Martin M, Andriani M, Cid E, Kazemzadeh M, Pisanello M Nat Methods. 2024; 22(2):371-379.
PMID: 39741190 DOI: 10.1038/s41592-024-02557-3.
Current preclinical models of brain metastasis.
Drouin Z, Levesque F, Mouzakitis K, Labrie M Clin Exp Metastasis. 2024; 42(1):5.
PMID: 39694975 DOI: 10.1007/s10585-024-10318-x.
Najafian K, Rehany B, Nowakowski A, Ghazimoghadam S, Pierre K, Zakarian R Neurooncol Adv. 2024; 6(1):vdae200.
PMID: 39679176 PMC: 11639946. DOI: 10.1093/noajnl/vdae200.
Potential of ex vivo organotypic slice cultures in neuro-oncology.
Steindl A, Valiente M Neuro Oncol. 2024; 27(2):338-351.
PMID: 39504579 PMC: 11812025. DOI: 10.1093/neuonc/noae195.